Recent structure analyses of αB-crystallin have proposed some models of the N-terminal domain and the manner of oligomerization, whereas the effects of the significantly high content of Pro residues at the N-terminal domain remain unclear.
Introduction
The transparency of eye lens cells is maintained by a highly abundant protein known as α-crystallin, which is composed of αAand αB-crystallins [1] . Both proteins belong to the small heat shock protein (sHSP) family and function as molecular chaperones to prevent the aggregation of other proteins when exposed to certain types of stress [2] . Structural anomalies such as point mutations of α-crystallin genes [3] or racemization and isomerization of certain residues by UV irradiation [4, 5] are known to cause human cataracts. The expression of αB-crystallin is widespread in many tissues, including muscle and brain, and has been implicated in myopathies [6] , Alexander disease [7] , and Alzheimer's disease [8] . For decades, researchers have attempted to describe the high-resolution structure of αB-crystallin, which is composed of a core structure conserved among all sHSPs that is referred to as the α-crystallin domain and highly flexible N-and C-terminal domains [9] . The crystal structures of truncated forms containing the α-crystallin domain and a portion of the C-terminal domain [10, 11] , together with solid-state NMR measurements of full-length αB-crystallin [12] , have demonstrated that a stable homodimer is formed by the β-sheets of the α-crystallin domain. However, the flexible N-and C-terminal domains yield diverse oligomerization states [13] and prevent the crystallization needed for high-resolution structure determination. Recent studies of a quaternary assembly of αB-crystallin based on EM, solid-state NMR, and small-angle X-ray scattering (SAXS) analyses proposed homo-oligomer models of 24-meric assembly [14, 15, 16] . The models also provide reasonable explanations for the heterogeneity of αB-crystallin via the dynamic exchange of the dimer subassemblies to form larger oligomerizations such as 26 and 28-mer, and up to 36-mer proteins.
On the other hand, these models differ significantly in terms of how contact is achieved between the N-and C-terminal domains and the neighboring subunit. Therefore, further structure analyses will be needed to elucidate the detailed oligomerization mechanism of αB-crystallin.
Several crystal structures of intact or artificially truncated proteins belonging to the sHSP family have been reported thus far. Wheat HSP16.9 [17] and HSP16.5 from
Methanococcus jannaschii (MjHSP16.5) [18] consist of 151 and 147 amino acids forming 12 and 24-meric homo-oligomers, respectively. These sHSPs are thought to be highly homologous to 24-meric αB-crystallin composed of 175 amino acids in the monomeric structure. Only in the crystal structure of wheat HSP16.9, almost the entire N-and C-terminal domain regions of the monomer have been identified. The N-terminal domain of wheat HSP16.9 exhibits an α-helix-rich structure, which is in good agreement with the proposed model of the N-terminal domain of αB-crystallin [16] .
The amino acid sequence alignment of αB-crystallin with wheat HSP16.9 and In this study, we investigated the properties of the oligomeric state and chaperone-like activity of the P39R mutant of αB-crystallin, a novel mutant designed based on protein structure information. Comparisons with the properties of wild-type αB-crystallin revealed that the N-terminal domain is involved in multiple interactions that enable the formation of various oligomers and binding to denatured proteins, thereby enabling chaperone-like activities.
Materials and methods

Expression and purification of recombinant wild-type and P39R mutant αB-crystallins
Escherichia coli BL21(DE3)pLysS was transformed with the vector pET-23d
containing human wild-type αB-crystallin cDNA (kind gift of Prof. L. Takemoto).
The cells were grown at 37ºC, and expression was induced by 0. The P39R mutation was introduced in the wild-type αB-crystallin cDNA using a KOD -Plus-Mutagenesis Kit (TOYOBO) and the mutagenic primer 
Circular dichroism (CD) spectroscopy
The far-UV CD spectra of the proteins were recorded by a J-805 spectropolarimeter (JASCO) at 25ºC. The protein concentration was 0.1 mg/ml in 0.1 mM buffer A.
A quartz cell with a path length of 1 mm was used, and the reported spectra are the average of five accumulations. The secondary structure contents of the proteins were analyzed using the program JWSSE-480.
Size-exclusion chromatography
The molecular size of the wild-type and the P39R mutant αB-crystallins was determined by size-exclusion chromatography on a 10 × 300 mm Sephacryl S-400 (GE healthcare) column, calibrated by the standard samples (GE healthcare) of thyroglobulin (669 kDa), ferritin (440 kDa), conalbumin (75 kDa), and ribonuclease A (13.7 kDa).
The column was equilibrated with 50 mM Tris-HCl pH 8.0 containing 150 mM NaCl.
The molecular size of the complexes of denatured proteins and αB-crystallins was determined by the same method.
Dynamic light scattering
Dynamic light scattering (DLS) measurements were carried out using a DynaPro 99 instrument (Protein Solutions). The samples were centrifuged to remove large aggregates and were then loaded onto a 12-µl sample cell (path length, 1.5 mm).
Data were analyzed using the program DYNAMICS version 5.26.56.
Chaperone-like activity assays
The chaperone-like activity of the wild-type and P39R mutant αB-crystallins was assessed by measuring the ability of these proteins to suppress the aggregation of denatured alcohol dehydrogenase (ADH) or insulin, essentially according to the previously reported methods [19, 20] . ADH (0.8 mg/ml) was denatured in 50 mM were removed by centrifuge before the samples were applied to the column.
Results and Discussion
Circular dichroism spectral studies
The secondary structures of the wild-type and P39R mutant αB-crystallins were determined by far-UV CD spectral analysis (Figure 2A and Table 1 ). As expected, the mutation of Pro39 to Arg increased the α-helix content from 19.5% to 22.9%. In contrast, the β-sheet content of the P39R mutant showed a reduction to 30.2%, reduced from 35.5% in the wild-type.
Few changes were observed in the β-turn and random coil contents. Because the highly conserved core domain is very stable with a dimer of β-sandwiches [10, 11, 12] and the C-terminal domain is thought to be highly flexible, it is likely that the changes in the secondary structure contents observed in the CD spectral analyses were due solely to structural changes at the N-terminal domain of the P39R mutant αB-crystallin. The predicted secondary structures of the N-terminal domain of wild-type αB-crystallin are composed of several helices and β-strands [15, 16] (Figure   1 ). Therefore, it was assumed that the structural changes induced by the mutation at Pro39 to Arg are primarily limited to the N-terminal domain of αB-crystallin. It has been reported that the conformation of the N-terminal domain is related to its oligomerization states [15, 16] , and that the deletion of the N-terminal domain results in a larger oligomer than that of the wild-type αB-crystallin [21] . Since the Pro residue generally acts as a structural disruptor in a regular α-helix, mutation at Pro39 to Arg contributes to increase α-helix content of the N-terminal domain of αB-crystallin.
Molecular size analyses
The molecular sizes of the oligomeric complexes of wild-type and P39R mutant αB-crystallins were estimated by size exclusion chromatography and DLS analyses.
Size exclusion chromatography analysis revealed slightly faster elution for the P39R mutant (calculated as ~620 kDa) than that of the wild-type αB-crystallin (calculated as ~510 kDa, Figure 2B ). These results were confirmed by the DLS data. The hydrodynamic radius of the wild-type and P39R mutant αB-crystallin was 8.0 and 8.3 nm, respectively ( Table 2 ). These findings indicate that the conformational change at the N-terminal domain would lead to the formation of a larger assembly than that of the 24-meric wild-type αB-crystallin. This hypothesis does not contradict the assembly architecture proposed by Jehle et al., in which the N-terminal domain in the 24-mer model is located around the binding area for another molecule to form even larger oligomers, such as 26 or 28-mer oligomers [16] . The conformation of the N-terminal domain of P39R mutant αB-crystallin would be preferred to form a larger assembly than that of wild-type αB-crystallin.
Chaperone-like activity
The suppression of aggregation was analyzed for denatured ADH and insulin ( Figure 3 ). In the ADH assay, the addition of 0.8 mg/ml of wild-type or P39R mutant αB-crystallin reduced aggregation to 10.2% and 17.2% of the control, respectively, at 2000 min. Fewer αB-crystallins caused a weak suppression of aggregation; the addition of 0.16 mg/ml of wild-type or P39R mutant αB-crystallin reduced aggregation to 69.0% and 80.8% of the control level, respectively. Thus, the P39R mutant displayed a slight loss of chaperone-like activity with respect to that of the wild-type αB-crystallin.
In contrast, the P39R mutant showed a significant increase in chaperone-like activity in the insulin assay. The addition of 0.16 mg/ml of wild-type or P39R mutant αB-crystallin reduced aggregation to 10.1% and 4.0% of the control level, respectively, at 2000 min. Dilution by half of the wild-type αB-crystallin (0.08 mg/ml) resulted in a much weaker suppression of aggregation, i.e., of 66.5% of the control, whereas dilution by half of the P39R mutant αB-crystallin retained to some extent of chaperone-like activity, i.e., of 20.7% of the control.
To elucidate how complexes are formed in chaperone-like activity assays, size exclusion chromatography was performed under conditions similar to those used for the chaperone-like activity assays. Protein concentrations were set to approximately ten times those used in the chaperone-like activity assays, in order to achieve clearer signals in the chromatograms and for subsequent PAGE analyses. For the assays of ADH and wild-type αB-crystallin, very large aggregates were eluted at the void volume, but a large portion of the αB-crystallin was eluted at 15.4 ml, just prior to the elution volume (16.0 ml) of the control of wild-type αB-crystallin ( Figure 4A ). The SDS-PAGE analysis of the void volume fraction demonstrated that the very large aggregates are derived from complexes of ADH and wild-type αB-crystallin, whereas the fraction at the highest peak contains primarily αB-crystallin and the fraction occurring just after the highest peak (shoulder peak at 17.0 ml) contains primarily ADH. These observations indicate that a few very large complexes (>10 MDa) of ADH and wild-type αB-crystallin are formed, but that a large portion of the αB-crystallin binds to no substrates or to only a small amount of substrate. Similar results were obtained in the assay of the ADH and P39R mutant αB-crystallin, except that the ratio of the peak of very large aggregates at the void volume to the main peak was reduced. For the assay of insulin and wild-type αB-crystallin, very large aggregates were also eluted at the void volume, but the highest peak (13.6 ml) of elution volume was observed significantly before that of the control of wild-type αB-crystallin ( Figure 4B ). The SDS-PAGE analysis demonstrated that both peaks are derived from complexes of insulin and wild-type αB-crystallin. Similar results were obtained for the assay of insulin and the P39R mutant αB-crystallin, except that the ratio of the peak of very large aggregates at the void volume to the main peak was significantly increased.
The generation of the very large aggregates at the void volume corresponded to the observed chaperone-like activities. Therefore, the chaperone-like activity of αB-crystallin would depend on how the very large aggregates, the molecular size of which was estimated at more than 10 MDa, were efficiently generated. It has been previously reported that residues 57-69 and 93-107 are involved in the binding with denatured ADH [22] . Residues 57-69 are located at the end of the N-terminal domain.
The conformational change at the N-terminal domain of the P39R mutant αB-crystallin would prevent residues 57-69 from interacting with denatured ADH, which would in turn suppress the formation of very large aggregates.
There is currently no information about the binding site for denatured insulin, but the mechanism of interaction clearly differs between the αB-crystallin-ADH and αB-crystallin-insulin complexes.
In the insulin assay, most wild-type and P39R mutant αB-crystallins formed complexes of approximately 2,200-2,800 kDa, whereas these complexes were not observed in the ADH assay. A major difference between the conditions used for the insulin and ADH assays was the molar ratio of the substrate proteins to αB-crystallins. For the insulin assay, the molar ratios of the substrate protein to αB-crystallins were about 60 times higher than those of the ADH assay.
Thus, complexes of approximately 2,200-2,800 kDa would have been responsible for the chaperone-like activity, in addition to the generation of very large aggregates at the void volume.
In conclusion, the conformational changes in the N-terminal domain of αB-crystallin induced by the mutation of Pro39 to Arg greatly affect the oligomerization and chaperone-like activity of αB-crystallin. It has been reported that the N-terminal domain of αB-crystallin is primarily important for both its oligomerization and chaperone-like activity [21] , and the hydrophobic region (residues 41-58) of the N-terminal domain is involved in the recognition of denatured proteins [23] . Our study demonstrated that the Pro39 is also a regulatory residue for the oligomerization and chaperone-like activity of αB-crystallin. The Pro-rich environment at the N-terminal domain of αB-crystallin would allow for the diversity of conformations of the N-terminal domain and is expected to be responsible for both polydisperse oligomerization and interactions with various denatured proteins. 
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